Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Group
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0127	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0127	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0127	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0128	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0148	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0183	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0205	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0210	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0249	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0316	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0318	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0329	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0502	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0564	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0629	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.0957	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1010	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1093	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1115	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1406	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1632	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1822	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.1938	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.2171	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.2883	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.2912	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.3542	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.3600	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.4347	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.4497	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.4757	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.5053	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.5102	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.5566	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.5860	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.6387	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.6533	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.6706	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.6725	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.7157	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.7231	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.7297	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.7815	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.7934	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8057	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8057	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8149	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8414	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8426	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8739	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8751	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8893	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.8991	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9100	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9444	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9534	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9562	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9732	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9939	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9942	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	0.9995	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0005	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0071	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0117	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0275	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0383	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0437	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0708	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0747	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0955	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0963	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.0970	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1021	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1113	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1278	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1388	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1544	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1600	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1840	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.1868	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.2092	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.2207	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.2587	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.2635	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.2939	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.3231	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.3501	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.3543	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.3659	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.3845	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.4208	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.4258	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.4383	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.4683	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.4688	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5027	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5082	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5118	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5198	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5315	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5354	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5594	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5668	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5890	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.5940	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.6052	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.6377	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.7369	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.8166	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.8467	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.9476	Peak area	Lean
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.9671	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	1.9866	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	2.0106	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	2.2383	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	2.3881	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	2.6543	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	2.8133	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	3.1318	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	N-carbamoylaspartate	3.3710	Peak area	Obese non neuropathy